Bibliographie

Publié le 12/05/2010

Article réservé aux abonnés

1- AFSSAPS, HAS. Traitement médicamenteux du diabète de type 2. Actualisation. Recommandations. Novembre 2006.

http://www.has-sante.fr/portail/upload/docs/application/pdf/recos_diabe…

2- UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352: 837-53.

3- Holman RR, Paul SK, Bethel MA et al. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes. N Engl J Med 2008;359:1577-89.

4- Gerstein HC, Miller ME, Byington RP et al. The Action to Control Cardiovascular Risk in Diabetes Study Grou. Effects of Intensive Glucose Lowering in Type 2 Diabetes. N Engl J Med 2008;358:2545-59.

5- The ADVANCE Collaborative Group. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med 2008;358:2560-72.

6- Duckworth W, Abraira C, Moritz t et al, for the VADT Investigators. Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes. N Engl J Med 2009;360: 129-39.

7- Halimi S. Vers de nouvelles recommandations de traitement du diabète de type 2 ? Point de vue d’un expert. Rev Prat 2010; 60: 504-9

8- AFSSAPS, HAS. Traitement médicamenteux du diabète de type 2. Actualisation. Argumentaire. Novembre 2006.

http://www.has-sante.fr/portail/upload/docs/application/pdf/argum_diabe…

9- Nathan DM, Buse JB, Davidson MB, et al. American Diabetes Association. European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203.